Jeanne Mueller, a professor emerita in the College of Human Ecology (CHE) who advised the U.S. and foreign governments on social services, died Nov. 2 in Rochester, New York. She was 100.
Patients taking an experimental oral GLP-1 drug lost significant weight and improved heart and metabolic risk factors in a large, international phase III clinical trial.
A federal stop-work order has threatened the progress a Weill Cornell Medicine researcher has made in understanding a lethal and treatment-resistant form of prostate cancer.
Imprint, an organization founded at Cornell Tech that is dedicated to decoding the body’s immune memory and uncovering the causes of chronic diseases, announced that it has raised over $15 million in funding.
The office is moving to Research & Innovation under the vice provost for research to integrate postdoctoral support more closely with Cornell’s research enterprise. The office provides career development and other resources for postdoctoral researchers.
Investigators at Weill Cornell Medicine and Cornell’s Ithaca campus will use a $5.1 million grant from the NIH to launch the Autism Replication, Validation, and Reproducibility Center, which aims to improve the reliability of autism research.
After a winter break to regroup and recharge, faculty, students, and staff return to campus and to the open questions, conversations, and explorations that will drive the work of the semester ahead.
Most health policy experts don’t think new Medicaid work requirements introduced in the One Big Beautiful Bill Act (OBBBA) would substantially increase employment among Medicaid-enrolled, working-age adults, according to a new survey from the Cornell Health Policy Insight Panel.
Wang's newly established role will strengthen Cornell Tech’s leadership in digital health and artificial intelligence, while also expanding interdisciplinary collaboration between Cornell Tech and Weill Cornell Medicine.